SCHEMBL4564446

SCHEMBL4564446

Cc1ccnc(-c2cccc(Cl)c2Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.42
CYP1A2 P05177 5/20 0.42
CYP3A4 P08684 5/20 0.42
CYP2C19 P33261 5/20 0.42
CYP2D6 P10635 4/20 0.42
CYP2C9 P11712 1/20 0.42
PDE2A O00408 1/20 0.40
PDE10A Q9Y233 1/20 0.40
MAPK1 P28482 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GBA1 P04062 1/20 0.39
CNR2 P34972 1/20 0.39
MAOA P21397 1/20 0.38
ADRA1A P35348 1/20 0.38
SCN4A P35499 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409010 0.86 CYP1A2 (0.53) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL2666286 0.83 KMO (0.47) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL8365594 0.80 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL6439475 0.79 CNR2 (0.50) GRM5CYP2D6MAPK1CNR2MAOA
SCHEMBL2666281 0.78 L3MBTL1 (0.40) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL9369946 0.78 GRM5 (0.46) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL24181632 0.77 GRM5 (0.33) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL1429685 0.76 CYP1A2 (0.43) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL10678910 0.74 DPP4 (0.44) GRM5CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL8365591 0.74 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C19CYP2D6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580857-B2 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy AU JESSIE L-S (US) 2013-11-12 US claimed
US-7625860-B2 Methods and compositions for modulating cell proliferation and cell death AU JESSIE L-S 2009-12-01 US disclosed
US-20040010001-A1 Methods and compositions for modulating cell proliferation and cell death AU JESSIE L-S (US) 2004-01-15 US disclosed
WO-2002076983-A1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2002-10-03 WO disclosed